Cargando…
Artificial Pancreas or Novel Beta-Cell Replacement Therapies: a Race for Optimal Glycemic Control?
PURPOSE OF REVIEW: New treatment strategies are needed for patients with type 1 diabetes (T1D). Closed loop insulin delivery and beta-cell replacement therapy are promising new strategies. This review aims to give an insight in the most relevant literature on this topic and to compare the two radica...
Autores principales: | Nijhoff, Michiel F., de Koning, Eelco J. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153567/ https://www.ncbi.nlm.nih.gov/pubmed/30250968 http://dx.doi.org/10.1007/s11892-018-1073-6 |
Ejemplares similares
-
Organoids from the Human Fetal and Adult Pancreas
por: Balak, Jeetindra R. A., et al.
Publicado: (2019) -
Heterogeneity in the Beta-Cell Population: a Guided Search Into Its Significance in Pancreas and in Implants
por: Pipeleers, Daniel, et al.
Publicado: (2017) -
Machine Perfusion and the Pancreas: Will It Increase the Donor Pool?
por: Hamaoui, Karim, et al.
Publicado: (2019) -
Pancreas-on-a-Chip Technology for Transplantation Applications
por: Abadpour, Shadab, et al.
Publicado: (2020) -
Pancreas Transplantation from Donors after Circulatory Death: an Irrational Reluctance?
por: Leemkuil, M., et al.
Publicado: (2019)